Is Ozempic approved for weight loss?

No. Ozempic is approved for type 2 diabetes (and related cardiovascular and kidney indications). Wegovy is the semaglutide product approved for weight management.

Published August 27, 2026 · updated August 27, 2026 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

Ozempic vs compounded semaglutide

Ozempic is semaglutide approved for type 2 diabetes; compounded semaglutide is an unapproved pharmacy preparation sold mostly for weight management. The indication difference and what it means for coverage and prescribing.

Ozempic

Semaglutide approved for glycaemic control in adults with type 2 diabetes, with additional indications relating to cardiovascular and kidney outcomes in that population. Once-weekly pen at doses up to 2 mg. Its evidence comes from the SUSTAIN programme and outcomes trials in people with diabetes. The same manufacturer’s product for weight management is Wegovy, dosed to 2.4 mg.

Off-label use and coverage

Clinicians may prescribe Ozempic for weight management; insurers generally cover it only with a type 2 diabetes diagnosis, and many telehealth providers will not prescribe it for weight management for that reason. Where a provider offers Ozempic, the profile records the indication and the coverage pathway as published.

Compounded semaglutide

Not FDA-approved, not tested in the semaglutide trials, and subject to the salt-form concerns FDA has raised. Evidence grade C for injectable compounded semaglutide on this site. The Wegovy comparison covers dosing, evidence and pricing in detail; all of it applies here.

For a patient with type 2 diabetes

The diabetes indication may bring insurance coverage for Ozempic that compounded semaglutide can never have. Hypoglycaemia with insulin or sulfonylureas and diabetic retinopathy complications are labelled warnings, and the label’s monitoring recommendations are part of why the prescribing decision belongs with a clinician who knows the full history.

Questions this page answers

Is Ozempic approved for weight loss?: No. Ozempic is approved for type 2 diabetes (and related cardiovascular and kidney indications). Wegovy is the semaglutide product approved for weight management.

Sources

Ozempic (semaglutide) prescribing information (label)
Wegovy (semaglutide) prescribing information (label)

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.